Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Xu, Xiaoyan  [Clear All Filters]
2024
Xu X, Xie T, Zhou M, Sun Y, Wang F, Tian Y, Chen Z, Xie Y, Wu R, Cen X, et al. Hsc70 promotes anti-tumor immunity by targeting PD-L1 for lysosomal degradation. Nat Commun. 2024;15(1):4237.
Yu P, Chen W, Jiang L, Jia Y, Xu X, Shen W, Jin N, Du H. Olfactory dysfunction and the role of stem cells in the regeneration of olfactory neurons. Heliyon. 2024;10(9):e29948.
2023
Xu X, Zhou T, Wei X, Jiang X, Cao J. Application of mPEG-CS-cRGD/-PTX nanoparticles in suppression of laryngeal cancer by targeting cancer stem cells. Drug Deliv. 2023;30(1):2180112.
Xu X, Wang H, Han H, Yao Y, Li X, Qi J, Cai C, Zhou M, Tang Y, Pan T, et al. Clinical characteristics and prognostic significance of DNA methylation regulatory gene mutations in acute myeloid leukemia. Clin Epigenetics. 2023;15(1):54.
Huang W, Zhou R, Jiang C, Wang J, Zhou Y, Xu X, Wang T, Li A, Zhang Y. Mitochondrial dysfunction is associated with hypertrophic cardiomyopathy in Pompe disease-specific induced pluripotent stem cell-derived cardiomyocytes. Cell Prolif. 2023:e13573.
2022
Yang J, Xu X, Han S, Qi J, Li X, Pan T, Zhang R, Han Y. Comparison of multiple treatments in the management of transplant-related thrombotic microangiopathy: a network meta-analysis. Ann Hematol. 2022.
Pan T, Qi J, Tang Y, Yao Y, Chen J, Wang H, Yang J, Xu X, Shi Q, Liu Y, et al. N-acetylcysteine as prophylactic therapy for transplant-associated thrombotic microangiopathy: a randomized, placebo-controlled trial. Transplant Cell Ther. 2022.
2020
Niu X, Xu X, Luo Z, Wu D, Tang J. The expression of Th9 and Th22 cells in rats with cerebral palsy after hUC-MSC transplantation. J Chin Med Assoc. 2020;83(1):60-66.
2018
Wang Y, Xu X, Maglic D, Dill MT, Mojumdar K, Ng PKwok-Shing, Jeong KJin, Tsang YHuen, Moreno D, Bhavana VHemanjani, et al. Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer. Cell Rep. 2018;25(5):1304-1317.e5.
2016
Wang L, Xu X, Kang L, Xiang W. Bone Marrow Mesenchymal Stem Cells Attenuate Mitochondria Damage Induced by Hypoxia in Mouse Trophoblasts. PLoS One. 2016;11(4):e0153729.